Ion Beam Applications (FRA:IOB) Cyclically Adjusted PS Ratio: (As of Sep. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:IOB Ion Beam Applications SA FRA:IOB
76 GF Score
Price €15.16
GF Value €15.95
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Ion Beam Applications Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Ion Beam Applications  (FRA:IOB) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Ion Beam Applications Cyclically Adjusted PS Ratio Related Terms


Ion Beam Applications Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Ion Beam Applications's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ion Beam Applications Cyclically Adjusted PS Ratio Chart

Ion Beam Applications Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.48 1.39 0.95 1.01 0.91

Ion Beam Applications Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.93 0.98 0.82 0.88 1.11

FRA:IOB vs ABT, SYK, MDT: Cyclically Adjusted PS Ratio Comparison

For the Medical Devices subindustry, Ion Beam Applications's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ion Beam Applications Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ion Beam Applications's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Ion Beam Applications's Cyclically Adjusted PS Ratio falls into.


FRA:IOB
76GF Score
Ion Beam Applications SA FRA:IOB
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ion Beam Applications Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Ion Beam Applications's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec25 is calculated as:

For example, Ion Beam Applications's adjusted Revenue per Share data for the fiscal year that ended in Dec25 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec25 (Change)*Current CPI (Dec25)
=20.472/135.0800*135.0800
=20.472

Current CPI (Dec25) = 135.0800.

Ion Beam Applications Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201612 11.149 102.614 14.676
201712 8.107 104.804 10.449
201812 8.779 107.252 11.057
201912 9.583 108.065 11.979
202012 10.499 108.511 13.070
202112 10.378 114.705 12.221
202212 11.972 126.578 12.776
202312 16.022 128.292 16.870
202412 16.896 132.346 17.245
202512 20.472 135.080 20.472

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Ion Beam Applications (FRA:IOB) Overvalued in 2026?

Based on GuruFocus' analysis, Ion Beam Applications stock appears to be undervalued. The current stock price of €15.16 is trading 5% below its estimated GF Value™ of €15.95. GuruFocus considers Ion Beam Applications to be Fairly Valued.

Key valuation signals for FRA:IOB:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: €15.95 vs. price of €15.16 (5% below fair value)
  • GF Score™: 76/100 with 6 warning signs

No single metric tells the full story. See the FRA:IOB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ion Beam Applications Business Description

Address Chemin du Cyclotron, 3, Louvain-La-Neuve, BEL, B-1348
Ion Beam Applications SA develops and manufactures medical devices and software solutions. The firm operates in three segments: IBA Clinical, including Proton Therapy and Dosimetry; IBA Technologies; and IBA Corporate. Proton therapy and other accelerators contribute to the majority of sales. It offers solutions for precision cancer treatment through the use of proton beams, as well as cyclotrons used for the production of radioisotopes and industrial accelerators for sterilization and ionization. The dosimetry business sells measurement and quality assurance instruments for radiotherapy and medical imaging. The firm operates in three geographical areas: Belgium, the United States, China, Germany, and India.
76GF Score

Get the complete analysis for FRA:IOB

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€15.16
Price
€15.95
GF Value